A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer-Reference-Cited by-同舟云学术

A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer

Published:2018-03 Issue: Volume:417 Page:131-140
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Lee Hyun Joo,Lee Woo Kyung,Kang Chan Woo,Ku Cheol Ryong,Cho Yoon Hee,Lee Eun Jig

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference65 articles.

1. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth;Yu;Mol. Canc. Therapeut.,2013

2. Management of anaplastic thyroid cancer;Keutgen;Gland Surg.,2015

3. Anaplastic thyroid carcinoma;Taccaliti;Front. Endocrinol.,2012

4. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas;Nikiforov;Endocr. Pathol.,2004

5. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies;Smallridge;Endocr. Relat. Canc.,2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of ribociclib on the expression levels of miR-141 and CDK4/6-USP51 signaling pathway genes in MCF-7 and MDA-MB-231 cells;PLOS ONE;2024-08-28

2. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas;Frontiers in Endocrinology;2023-10-26

3. Targeting cyclin D1 as a therapeutic approach for papillary thyroid carcinoma;Frontiers in Oncology;2023-06-22

4. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer;Cell Cycle;2023-06-22

5. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas;2023-06-07